| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $324.9M | — | -11.2% |
| R&D Expense | $10.0M | — | -9.1% |
| SG&A Expense | $59.2M | — | -27.7% |
| Operating Income | $16.9M | — | +142.0% |
| Interest Expense | $26.4M | — | +2.8% |
| Pre-tax Income | -$6.5M | — | +89.5% |
| Income Tax | $1.2M | — | +109.7% |
| Net Income | -$7.7M | — | +84.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $101.6M | -14.4% | -34.0% |
| Inventory | $186.2M | +2.1% | +16.1% |
| Current Assets | $703.7M | -5.8% | -5.0% |
| Total Assets | $1.90B | -4.7% | -44.3% |
| Current Liabilities | $1.99B | -2.0% | +311.5% |
| Long-term Debt | $1.53B | -0.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$999K | — | -126.5% |
| Capital Expenditures | $11.6M | — | -63.3% |
| Investing Cash Flow | -$13.5M | — | +75.8% |
| Financing Cash Flow | -$2.5M | — | -247.1% |
| Free Cash Flow | -$12.6M | — | +54.8% |
| -0.8% |
| Total Liabilities | $2.76B | -3.1% | -9.8% |
| Stockholders' Equity | -$900.4M | -0.4% | -396.5% |